Take a fresh look at your lifestyle.

President Tinubu appoints new DG of NIMR

271

President Bola Tinubu has appointed Professor John Oladapo Obafunwa as the new Director-General of the Nigerian Institute of Medical Research (NIMR).

This was disclosed in a statement by his spokesman, Chief Ajuri Ngelale.

Mr Tinubu said the appointment takes effect from Wednesday, July 24, 2024.

Obafunwa succeeds Professor Babatunde Salako, whose tenure expires on July 23, 2024.

“Professor Obafunwa brings a wealth of experience and a diverse background to the role. He qualified in medicine from the University of Lagos in 1980 and specialized in Anatomic Pathology, graduating in May 1987.

“He further sub-specialized in Forensic Pathology in Scotland in 1991 and obtained a law degree from England in 2004.

“Obafunwa has held various positions in the medical field, both internationally and domestically. His previous roles include working in the Cayman Islands, Bermuda, and the UK, and upon returning to Nigeria in 2004, he took up an appointment as Professor of Forensic Pathology at Lagos State University College of Medicine (LASUCOM).

“He has served as Provost of LASUCOM, Chief Medical Examiner for Lagos State, and Vice-Chancellor of Lagos State University. Before his current appointment, he was the International Regional Advisor of the Royal College of Pathologists (UK) for Sub-Saharan Africa.

“With numerous scientific publications and contributions to textbooks, Professor Obafunwa’s research interests include anatomic and forensic pathology.

“He is currently involved in research in forensic entomology and taphonomy at the University of Nebraska, USA.

“President Tinubu expressed confidence that Professor Obafunwa’s extensive qualifications and experience will further the NIMR’s mission of leading research into public health diseases in Nigeria, enhancing the dissemination of research findings, and providing a conducive environment for health research and training in collaboration with federal and state health ministries”, the statement reads.